Selected research
Industry Research
Immune System Allergy Treatment Industry Research Report 2026
Market perspective
The global Immune System Allergy Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Immune System Allergy Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Immune System Allergy Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Immune System Allergy Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Immune System Allergy Treatment include Sanofi, Johnson and Johnson Services, Inc., Pfizer Inc., GlaxoSmithKline plc, Stallergenes Greer, LETIPharma, Dermapharm Holding, Allergy Therapeutics and Allergan plc and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Immune System Allergy Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Immune System Allergy Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immune System Allergy Treatment Market by Company
Sanofi
Johnson and Johnson Services, Inc.
Pfizer Inc.
GlaxoSmithKline plc
Stallergenes Greer
LETIPharma
Dermapharm Holding
Allergy Therapeutics
Allergan plc
ALK-Abelló A/S
Immune System Allergy Treatment Segment by Type
Allergy Injection
Sublingual Immunotherapy
Immune System Allergy Treatment Segment by Application
Hospital
Clinic
Others
Immune System Allergy Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune System Allergy Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune System Allergy Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune System Allergy Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Immune System Allergy Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Allergy Injection
- Sublingual Immunotherapy
Applications
- Hospital
- Clinic
- Others
Companies covered
- Sanofi
- Johnson and Johnson Services, Inc.
- Pfizer Inc.
- GlaxoSmithKline plc
- Stallergenes Greer
- LETIPharma
- Dermapharm Holding
- Allergy Therapeutics
- Allergan plc
- ALK-Abelló A/S
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Immune System Allergy Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Allergy Injection
- 2.2.3 Sublingual Immunotherapy
- 2.3 Immune System Allergy Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Immune System Allergy Treatment Breakdown Data by Type
- 3.1 Global Immune System Allergy Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Immune System Allergy Treatment Forecasted Market Size by Type (2027-2032)
4 Immune System Allergy Treatment Breakdown Data by Application
- 4.1 Global Immune System Allergy Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Immune System Allergy Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Immune System Allergy Treatment Market Perspective (2021-2032)
- 5.2 Global Immune System Allergy Treatment Growth Trends by Region
- 5.2.1 Global Immune System Allergy Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Immune System Allergy Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Immune System Allergy Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Immune System Allergy Treatment Market Dynamics
- 5.3.1 Immune System Allergy Treatment Industry Trends
- 5.3.2 Immune System Allergy Treatment Market Drivers
- 5.3.3 Immune System Allergy Treatment Market Challenges
- 5.3.4 Immune System Allergy Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Immune System Allergy Treatment Players by Revenue
- 6.1.1 Global Top Immune System Allergy Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Immune System Allergy Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Immune System Allergy Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Immune System Allergy Treatment Head Office and Area Served
- 6.4 Global Immune System Allergy Treatment Players, Product Type & Application
- 6.5 Global Immune System Allergy Treatment Manufacturers Established Date
- 6.6 Global Immune System Allergy Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Immune System Allergy Treatment Market Size (2021-2032)
- 7.2 North America Immune System Allergy Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Immune System Allergy Treatment Market Size by Country (2021-2026)
- 7.4 North America Immune System Allergy Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Immune System Allergy Treatment Market Size (2021-2032)
- 8.2 Europe Immune System Allergy Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Immune System Allergy Treatment Market Size by Country (2021-2026)
- 8.4 Europe Immune System Allergy Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Immune System Allergy Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Immune System Allergy Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Immune System Allergy Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Immune System Allergy Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Immune System Allergy Treatment Market Size (2021-2032)
- 10.2 South America Immune System Allergy Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Immune System Allergy Treatment Market Size by Country (2021-2026)
- 10.4 South America Immune System Allergy Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Immune System Allergy Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Immune System Allergy Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Immune System Allergy Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Immune System Allergy Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Sanofi
- 12.1.1 Sanofi Company Information
- 12.1.2 Sanofi Business Overview
- 12.1.3 Sanofi Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.1.4 Sanofi Immune System Allergy Treatment Product Portfolio
- 12.1.5 Sanofi Recent Developments
- 12.2 Johnson and Johnson Services, Inc.
- 12.2.1 Johnson and Johnson Services, Inc. Company Information
- 12.2.2 Johnson and Johnson Services, Inc. Business Overview
- 12.2.3 Johnson and Johnson Services, Inc. Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.2.4 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Portfolio
- 12.2.5 Johnson and Johnson Services, Inc. Recent Developments
- 12.3 Pfizer Inc.
- 12.3.1 Pfizer Inc. Company Information
- 12.3.2 Pfizer Inc. Business Overview
- 12.3.3 Pfizer Inc. Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.3.4 Pfizer Inc. Immune System Allergy Treatment Product Portfolio
- 12.3.5 Pfizer Inc. Recent Developments
- 12.4 GlaxoSmithKline plc
- 12.4.1 GlaxoSmithKline plc Company Information
- 12.4.2 GlaxoSmithKline plc Business Overview
- 12.4.3 GlaxoSmithKline plc Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.4.4 GlaxoSmithKline plc Immune System Allergy Treatment Product Portfolio
- 12.4.5 GlaxoSmithKline plc Recent Developments
- 12.5 Stallergenes Greer
- 12.5.1 Stallergenes Greer Company Information
- 12.5.2 Stallergenes Greer Business Overview
- 12.5.3 Stallergenes Greer Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.5.4 Stallergenes Greer Immune System Allergy Treatment Product Portfolio
- 12.5.5 Stallergenes Greer Recent Developments
- 12.6 LETIPharma
- 12.6.1 LETIPharma Company Information
- 12.6.2 LETIPharma Business Overview
- 12.6.3 LETIPharma Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.6.4 LETIPharma Immune System Allergy Treatment Product Portfolio
- 12.6.5 LETIPharma Recent Developments
- 12.7 Dermapharm Holding
- 12.7.1 Dermapharm Holding Company Information
- 12.7.2 Dermapharm Holding Business Overview
- 12.7.3 Dermapharm Holding Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.7.4 Dermapharm Holding Immune System Allergy Treatment Product Portfolio
- 12.7.5 Dermapharm Holding Recent Developments
- 12.8 Allergy Therapeutics
- 12.8.1 Allergy Therapeutics Company Information
- 12.8.2 Allergy Therapeutics Business Overview
- 12.8.3 Allergy Therapeutics Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.8.4 Allergy Therapeutics Immune System Allergy Treatment Product Portfolio
- 12.8.5 Allergy Therapeutics Recent Developments
- 12.9 Allergan plc
- 12.9.1 Allergan plc Company Information
- 12.9.2 Allergan plc Business Overview
- 12.9.3 Allergan plc Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.9.4 Allergan plc Immune System Allergy Treatment Product Portfolio
- 12.9.5 Allergan plc Recent Developments
- 12.10 ALK-Abelló A/S
- 12.10.1 ALK-Abelló A/S Company Information
- 12.10.2 ALK-Abelló A/S Business Overview
- 12.10.3 ALK-Abelló A/S Revenue in Immune System Allergy Treatment Business (2021-2026)
- 12.10.4 ALK-Abelló A/S Immune System Allergy Treatment Product Portfolio
- 12.10.5 ALK-Abelló A/S Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst